DE602004015966D1 - Lipidregulierendes mittel und dessen verwendung - Google Patents
Lipidregulierendes mittel und dessen verwendungInfo
- Publication number
- DE602004015966D1 DE602004015966D1 DE602004015966T DE602004015966T DE602004015966D1 DE 602004015966 D1 DE602004015966 D1 DE 602004015966D1 DE 602004015966 T DE602004015966 T DE 602004015966T DE 602004015966 T DE602004015966 T DE 602004015966T DE 602004015966 D1 DE602004015966 D1 DE 602004015966D1
- Authority
- DE
- Germany
- Prior art keywords
- lipid regulating
- regulating medium
- lipid
- medium
- regulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000002632 lipids Chemical class 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Mycology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003100408 | 2003-04-03 | ||
PCT/JP2004/004079 WO2004089964A1 (ja) | 2003-04-03 | 2004-03-24 | 脂質調節剤及びその用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004015966D1 true DE602004015966D1 (de) | 2008-10-02 |
Family
ID=33156723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004015966T Expired - Lifetime DE602004015966D1 (de) | 2003-04-03 | 2004-03-24 | Lipidregulierendes mittel und dessen verwendung |
Country Status (7)
Country | Link |
---|---|
US (2) | US20060276432A1 (de) |
EP (1) | EP1616873B1 (de) |
JP (1) | JP4893981B2 (de) |
CN (1) | CN100540559C (de) |
DE (1) | DE602004015966D1 (de) |
TW (1) | TW200501964A (de) |
WO (1) | WO2004089964A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4702745B2 (ja) * | 2003-07-18 | 2011-06-15 | 株式会社林原生物化学研究所 | ミネラル吸収促進剤及びその用途 |
US7973021B2 (en) * | 2005-09-22 | 2011-07-05 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Immunomodulating agent in gut |
JP2007267618A (ja) * | 2006-03-30 | 2007-10-18 | Mukogawa Gakuin | ケーキ |
JP2010053122A (ja) * | 2008-07-31 | 2010-03-11 | Hayashibara Biochem Lab Inc | 脂質合成阻害剤 |
US8629121B2 (en) | 2009-01-27 | 2014-01-14 | World Force Technologies, Llc | High molecular weight polysaccharide that binds and inhibits virus |
JP2010215544A (ja) * | 2009-03-13 | 2010-09-30 | Hiroshima Univ | 血管新生抑制剤、これを含有する医薬、血管新生抑制剤を産生させる整腸剤、並びに、血管新生抑制剤の投与方法 |
JP2014185088A (ja) * | 2013-03-22 | 2014-10-02 | Sunstar Inc | 経口組成物、脂肪細胞分化抑制剤および飲食品 |
WO2017084234A1 (zh) * | 2015-11-19 | 2017-05-26 | 欣耀生医股份有限公司 | 预防或治疗脂肪肝的药物组合物 |
JP7136765B2 (ja) | 2017-03-24 | 2022-09-13 | 株式会社林原 | オートファジー誘導剤とその用途 |
FR3087339A1 (fr) * | 2018-10-22 | 2020-04-24 | Nexira | Composition pour traiter le surpoids et/ou l'obesite |
JP7595018B2 (ja) | 2019-10-04 | 2024-12-05 | ナガセヴィータ株式会社 | 環状四糖を含有する糖組成物とその用途並びに製造方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6094912A (ja) * | 1983-10-28 | 1985-05-28 | Masashige Suzuki | 体内中性脂肪低減剤 |
JPH07115934A (ja) * | 1993-10-22 | 1995-05-09 | Hairu:Kk | 痩身用食品 |
JPH08283154A (ja) * | 1995-04-12 | 1996-10-29 | Nippon Shinyaku Co Ltd | 脂質代謝改善剤 |
US5786196A (en) * | 1995-06-12 | 1998-07-28 | The United States Of America As Represented By The Secretary Of Agriculture | Bacteria and enzymes for production of alternan fragments |
US7192746B2 (en) * | 2000-05-22 | 2007-03-20 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | α-Isomaltosyltransferase, process for producing the same and use thereof |
TWI312369B (en) | 2000-08-01 | 2009-07-21 | Hayashibara Biochem Lab | A-isomaltosylglucosaccharide synthase,process for producing the same and use thereof |
US7223570B2 (en) * | 2001-03-09 | 2007-05-29 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Branched cyclic tetrasaccharide, process for producing the same, and use |
JP2003160595A (ja) * | 2001-11-20 | 2003-06-03 | Hayashibara Biochem Lab Inc | 糖誘導体 |
-
2004
- 2004-03-24 DE DE602004015966T patent/DE602004015966D1/de not_active Expired - Lifetime
- 2004-03-24 WO PCT/JP2004/004079 patent/WO2004089964A1/ja active IP Right Grant
- 2004-03-24 EP EP04722989A patent/EP1616873B1/de not_active Expired - Lifetime
- 2004-03-24 CN CNB2004800086261A patent/CN100540559C/zh not_active Expired - Fee Related
- 2004-03-24 JP JP2005505191A patent/JP4893981B2/ja not_active Expired - Fee Related
- 2004-03-24 US US10/551,765 patent/US20060276432A1/en not_active Abandoned
- 2004-03-29 TW TW093108535A patent/TW200501964A/zh not_active IP Right Cessation
-
2008
- 2008-02-19 US US12/033,654 patent/US8940715B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN100540559C (zh) | 2009-09-16 |
US20060276432A1 (en) | 2006-12-07 |
TW200501964A (en) | 2005-01-16 |
US8940715B2 (en) | 2015-01-27 |
EP1616873B1 (de) | 2008-08-20 |
WO2004089964A1 (ja) | 2004-10-21 |
WO2004089964A8 (ja) | 2004-12-29 |
EP1616873A4 (de) | 2007-01-10 |
US20080214499A1 (en) | 2008-09-04 |
JP4893981B2 (ja) | 2012-03-07 |
EP1616873A1 (de) | 2006-01-18 |
CN1768071A (zh) | 2006-05-03 |
TWI330085B (de) | 2010-09-11 |
JPWO2004089964A1 (ja) | 2006-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE391718T1 (de) | Phenylacetamide und ihre verwendung als glukokinase-modulatoren | |
DE602005013491D1 (de) | Benzamidderivate und deren verwendung als glucokinaseaktivierende mittel | |
DE502004006612D1 (de) | Herbizid wirksames mittel | |
HK1092923A1 (en) | An electrophoretic medium and an electrophoretic display comprising the electrophoretic medium | |
DE60302378D1 (de) | Optisches Aufzeichnungsmedium und zugehöriges Aufzeichnungsverfahren | |
DE602004021037D1 (de) | Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren | |
ATE479437T1 (de) | Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung | |
DE602005003186D1 (de) | Fluorkopolymer und dessen Verwendung | |
ATE529420T1 (de) | 3-ä(2-ää4-hexyloxycarbonylamino-imino-methyl)- phenylaminoü-methylü-1-methyl-1h-benzimidazol-5 carbonyl)-pyridin-2-yl-aminoü-propionsäure- ethylester-methansulfonat-hemihydrat und dessen verwendung als arzneimittel | |
DE602004026860D1 (de) | Objektidentifikationsmedium und identifikationsverfahren | |
DE602004021904D1 (de) | Gyraseinhibitoren und deren verwendungen | |
ATE455629T1 (de) | Rasierer und kassetten | |
DE602004029844D1 (de) | Pigmentdispersion und deren Verwendung | |
EP1746902A4 (de) | Multilektin-affiniätschromatografie und verwendung dafür | |
EP1691661A4 (de) | Lösliche tcr-moleküle und anwendungsverfahren | |
EP1694118A4 (de) | Gewebekonservierungsmedien | |
ATE432701T1 (de) | Indol-6-sulfonamid-derivate, ihre herstellung und ihre verwendung als 5-ht-6 modulatoren | |
DE602004021384D1 (de) | Indol-5 -sulfonamid-derivate, ihre herstellung und verwendung als 5-ht-6 modulatoren | |
DE602004015966D1 (de) | Lipidregulierendes mittel und dessen verwendung | |
DE60230162D1 (de) | Polymerisate und ihre verwendung | |
DE60005784D1 (de) | Heizmedium und dessen Verwendung | |
DE10338270B4 (de) | Variator und Variatoranordnung | |
DE602004018678D1 (de) | Film und den film verwendendes magnetaufzeichnungsmedium | |
DE602004010815D1 (de) | Fluidproduktabgabekopf und dessen verwendung | |
DK1736159T3 (da) | Hudplejemiddel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |